BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 25132800)

  • 1. A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer.
    Sharma G; Dua P; Agarwal SM
    Curr Genomics; 2014 Aug; 15(4):310-23. PubMed ID: 25132800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic study on dysregulated microRNAs in cervical cancer development.
    He Y; Lin J; Ding Y; Liu G; Luo Y; Huang M; Xu C; Kim TK; Etheridge A; Lin M; Kong D; Wang K
    Int J Cancer; 2016 Mar; 138(6):1312-27. PubMed ID: 26032913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as markers of progression in cervical cancer: a systematic review.
    Pardini B; De Maria D; Francavilla A; Di Gaetano C; Ronco G; Naccarati A
    BMC Cancer; 2018 Jun; 18(1):696. PubMed ID: 29945565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Papillomavirus, MicroRNA and their Role in Cervical Cancer Progression, Diagnosis and Treatment Response: A Comprehensive Review.
    Jamal A; Shahid I; Naveed Shahid M; Saleh Alshmemri M; Saeed Bahwerth F
    Pak J Biol Sci; 2020 Jan; 23(8):977-988. PubMed ID: 32700847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.
    Babion I; Snoek BC; Novianti PW; Jaspers A; van Trommel N; Heideman DAM; Meijer CJLM; Snijders PJF; Steenbergen RDM; Wilting SM
    Clin Epigenetics; 2018; 10():76. PubMed ID: 29930741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs are involved in cervical cancer development, progression, clinical outcome and improvement treatment response (Review).
    González-Quintana V; Palma-Berré L; Campos-Parra AD; López-Urrutia E; Peralta-Zaragoza O; Vazquez-Romo R; Pérez-Plasencia C
    Oncol Rep; 2016 Jan; 35(1):3-12. PubMed ID: 26530778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of microRNAs in gynecological pathology.
    Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
    Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide discovery of viral microRNAs based on phylogenetic analysis and structural evolution of various human papillomavirus subtypes.
    Weng SL; Huang KY; Weng JT; Hung FY; Chang TH; Lee TY
    Brief Bioinform; 2018 Nov; 19(6):1102-1114. PubMed ID: 28531277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-Based Fingerprinting of Cervical Lesions and Cancer.
    Pisarska J; Baldy-Chudzik K
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33203149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of microRNAs in the treatment and diagnosis of cervical cancer.
    Shen S; Zhang S; Liu P; Wang J; Du H
    Cancer Genet; 2020 Oct; 248-249():25-30. PubMed ID: 32987255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression variability in human cervical tissues.
    Pereira PM; Marques JP; Soares AR; Carreto L; Santos MA
    PLoS One; 2010 Jul; 5(7):e11780. PubMed ID: 20668671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical Cancer, Papillomavirus, and miRNA Dysfunction.
    Bañuelos-Villegas EG; Pérez-yPérez MF; Alvarez-Salas LM
    Front Mol Biosci; 2021; 8():758337. PubMed ID: 34957212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of cervical cancer and HPV infection in Korea.
    Kim YT
    J Gynecol Oncol; 2009 Mar; 20(1):1-7. PubMed ID: 19471667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.
    Nair VB; Manasa VG; Sinto MS; Jayasree K; James FV; Kannan S
    Int J Gynecol Cancer; 2018 Mar; 28(3):553-562. PubMed ID: 29466255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From squamous intraepithelial lesions to cervical cancer: Circulating microRNAs as potential biomarkers in cervical carcinogenesis.
    Berti FCB; Salviano-Silva A; Beckert HC; de Oliveira KB; Cipolla GA; Malheiros D
    Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188306. PubMed ID: 31398380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of critical microRNA gene targets in cervical cancer using network properties.
    Sharma G; Agarwal SM
    Microrna; 2014; 3(1):37-44. PubMed ID: 25069511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of key microRNAs /TFs /mRNAs/ in HPV-positive cervical cancer based on microRNA sequencing and bioinformatics analysis.
    Yuan Y; Shi X; Li B; Peng M; Zhu T; Lv G; Liu L; Jin H; Li L; Qin D
    Pathol Res Pract; 2020 Jun; 216(6):152952. PubMed ID: 32307200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of microRNAs as biomarkers of cervical carcinogenesis: a systematic review.
    Nagandla K; Lin KH; Chitra E; Jamli MFBM
    Obstet Gynecol Sci; 2021 Sep; 64(5):419-436. PubMed ID: 34384196
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.